HEALTH● LOWAug 7 · Aug 7, 2026, 5:16 PM
GLP-1 Drug Linked to Heart Benefits for High-Risk Patients
Human Progress
“Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ today… A total of 52,971 individuals were included […] The post GLP-1 Drug Linked to Heart Benefits for High-Risk Patients appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH34m agoClinical trial saves man initially given weeks to live: "Not done yet"CBS NewsHEALTH1h agoEbola: Uganda restricts transit for travellers from DRCPremium TimesHEALTH1h agoBayern say coach Kompany ‘stable’ in hospital but will be out for weeksAl Jazeera [en]HEALTH2h agoA new understanding of alcohol problemsjournalreview.com · United States